Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
35712048
TITLE
Identifying the Common Genetic Basis of Antidepressant Response.
ABSTRACT
Background NlmCategory: UNASSIGNED
Antidepressants are a first-line treatment for depression. However, only a third of individuals experience remission after the first treatment. Common genetic variation, in part, likely regulates antidepressant response, yet the success of previous genome-wide association studies has been limited by sample size. This study performs the largest genetic analysis of prospectively assessed antidepressant response in major depressive disorder to gain insight into the underlying biology and enable out-of-sample prediction.
Methods NlmCategory: UNASSIGNED
Antidepressants are a first-line treatment for depression. However, only a third of individuals experience remission after the first treatment. Common genetic variation, in part, likely regulates antidepressant response, yet the success of previous genome-wide association studies has been limited by sample size. This study performs the largest genetic analysis of prospectively assessed antidepressant response in major depressive disorder to gain insight into the underlying biology and enable out-of-sample prediction. Genome-wide analysis of remission (  = 1852,  = 3299) and percentage improvement (  = 5218) was performed. Single nucleotide polymorphism-based heritability was estimated using genome-wide complex trait analysis. Genetic covariance with eight mental health phenotypes was estimated using polygenic scores/AVENGEME. Out-of-sample prediction of antidepressant response polygenic scores was assessed. Gene-level association analysis was performed using MAGMA and transcriptome-wide association study. Tissue, pathway, and drug binding enrichment were estimated using MAGMA.
Results NlmCategory: UNASSIGNED
Antidepressants are a first-line treatment for depression. However, only a third of individuals experience remission after the first treatment. Common genetic variation, in part, likely regulates antidepressant response, yet the success of previous genome-wide association studies has been limited by sample size. This study performs the largest genetic analysis of prospectively assessed antidepressant response in major depressive disorder to gain insight into the underlying biology and enable out-of-sample prediction. Genome-wide analysis of remission (  = 1852,  = 3299) and percentage improvement (  = 5218) was performed. Single nucleotide polymorphism-based heritability was estimated using genome-wide complex trait analysis. Genetic covariance with eight mental health phenotypes was estimated using polygenic scores/AVENGEME. Out-of-sample prediction of antidepressant response polygenic scores was assessed. Gene-level association analysis was performed using MAGMA and transcriptome-wide association study. Tissue, pathway, and drug binding enrichment were estimated using MAGMA. Neither genome-wide association study identified genome-wide significant associations. Single nucleotide polymorphism-based heritability was significantly different from zero for remission (  = 0.132, SE = 0.056) but not for percentage improvement (  = -0.018, SE = 0.032). Better antidepressant response was negatively associated with genetic risk for schizophrenia and positively associated with genetic propensity for educational attainment. Leave-one-out validation of antidepressant response polygenic scores demonstrated significant evidence of out-of-sample prediction, though results varied in external cohorts. Gene-based analyses identified and as significantly associated with antidepressant response.
Conclusions NlmCategory: UNASSIGNED
Antidepressants are a first-line treatment for depression. However, only a third of individuals experience remission after the first treatment. Common genetic variation, in part, likely regulates antidepressant response, yet the success of previous genome-wide association studies has been limited by sample size. This study performs the largest genetic analysis of prospectively assessed antidepressant response in major depressive disorder to gain insight into the underlying biology and enable out-of-sample prediction. Genome-wide analysis of remission (  = 1852,  = 3299) and percentage improvement (  = 5218) was performed. Single nucleotide polymorphism-based heritability was estimated using genome-wide complex trait analysis. Genetic covariance with eight mental health phenotypes was estimated using polygenic scores/AVENGEME. Out-of-sample prediction of antidepressant response polygenic scores was assessed. Gene-level association analysis was performed using MAGMA and transcriptome-wide association study. Tissue, pathway, and drug binding enrichment were estimated using MAGMA. Neither genome-wide association study identified genome-wide significant associations. Single nucleotide polymorphism-based heritability was significantly different from zero for remission (  = 0.132, SE = 0.056) but not for percentage improvement (  = -0.018, SE = 0.032). Better antidepressant response was negatively associated with genetic risk for schizophrenia and positively associated with genetic propensity for educational attainment. Leave-one-out validation of antidepressant response polygenic scores demonstrated significant evidence of out-of-sample prediction, though results varied in external cohorts. Gene-based analyses identified and as significantly associated with antidepressant response. This study demonstrates that antidepressant response is influenced by common genetic variation, has a genetic overlap schizophrenia and educational attainment, and provides a useful resource for future research. Larger sample sizes are required to attain the potential of genetics for understanding and predicting antidepressant response.
© 2021 The Authors.
DATE PUBLISHED
2022 Apr
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2021/04/29
revised 2021/07/15
accepted 2021/07/19
entrez 2022/06/17 02:36
pubmed 2022/06/18 06:00
medline 2022/06/18 06:01
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Pain O Pain Oliver O Social, Genetic and Developmental Psychiatry Centre, King's College London, London, United Kingdom.
Hodgson K Hodgson Karen K Social, Genetic and Developmental Psychiatry Centre, King's College London, London, United Kingdom.
Trubetskoy V Trubetskoy Vassily V Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Medical Psychology, Berlin, Germany.
Ripke S Ripke Stephan S Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Marshe VS Marshe Victoria S VS Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Adams MJ Adams Mark J MJ Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Byrne EM Byrne Enda M EM Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
Campos AI Campos Adrian I AI Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Carrillo-Roa T Carrillo-Roa Tania T Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
Cattaneo A Cattaneo Annamaria A Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Als TD Als Thomas D TD Center for Genomics and Personalized Medicine, Central Region Denmark and Aarhus University, Aarhus, Denmark.
Souery D Souery Daniel D Centre Européen de Psychologie Medicale (PsyPluriel), Brussels, Belgium.
Dernovsek MZ Dernovsek Mojca Z MZ University Psychiatric Clinic, University of Ljubliana, Ljubljana, Slovakia.
Fabbri C Fabbri Chiara C Social, Genetic and Developmental Psychiatry Centre, King's College London, London, United Kingdom.
Hayward C Hayward Caroline C MRC Human Genetics Unit, University of Edinburgh, Edinburgh, United Kingdom.
Henigsberg N Henigsberg Neven N Department of Psychiatry, Croatian Institute for Brain Research, University of Zagreb Medical School, Zagreb, Croatia.
Hauser J Hauser Joanna J Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
Kennedy JL Kennedy James L JL Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Lenze EJ Lenze Eric J EJ Healthy Mind Lab, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Lewis G Lewis Glyn G Division of Psychiatry, University College London, London, United Kingdom.
Müller DJ Müller Daniel J DJ Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Martin NG Martin Nicholas G NG Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Mulsant BH Mulsant Benoit H BH Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Mors O Mors Ole O Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Perroud N Perroud Nader N Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.
Porteous DJ Porteous David J DJ Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Rentería ME Rentería Miguel E ME Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Reynolds CF 3rd Reynolds Charles F CF Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.
Rietschel M Rietschel Marcella M Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Heidelberg University Faculty of Medicine in Mannheim, Mannheim, Germany.
Uher R Uher Rudolf R Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Wigmore EM Wigmore Eleanor M EM Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Maier W Maier Wolfgang W Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
Wray NR Wray Naomi R NR Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
Aitchison KJ Aitchison Katherine J KJ Department of Medical Genetics, Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
Arolt V Arolt Volker V Department of Psychiatry, University of Münster, Münster, Germany.
Baune BT Baune Bernhard T BT Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Biernacka JM Biernacka Joanna M JM Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Bondolfi G Bondolfi Guido G Department of Psychiatry, Geneva University Hospitals, Geneva, Switzerland.
Domschke K Domschke Katharina K Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
Kato M Kato Masaki M Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
Li QS Li Qingqin S QS Neuroscience Therapeutic Area, Janssen Research and Development, LLC, Titusville, New Jersey.
Liu YL Liu Yu-Li YL Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taipei, Taiwan.
Serretti A Serretti Alessandro A Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Tsai SJ Tsai Shih-Jen SJ Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Turecki G Turecki Gustavo G Department of Psychiatry, Douglas Institute, McGill University, Montreal, Quebec, Canada.
Weinshilboum R Weinshilboum Richard R Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
GSRD Consortium
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
McIntosh AM McIntosh Andrew M AM Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Lewis CM Lewis Cathryn M CM Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
INVESTIGATORS
LASTNAME FORENAME INITIALS AFFILIATION
Kasper Siegfried S
Zohar Joseph J
Souery Daniel D
Montgomery Stuart S
Albani Diego D
Forloni Gianluigi G
Ferentinos Panagiotis P
Rujescu Dan D
Mendlewicz Julien J
Wray Naomi R NR
Ripke Stephan S
Mattheisen Manuel M
Trzaskowski Maciej M
Byrne Enda M EM
Abdellaoui Abdel A
Adams Mark J MJ
Agerbo Esben E
Air Tracy M TM
Andlauer Till Fm TF
Bacanu Silviu-Alin SA
Bækvad-Hansen Marie M
Beekman Aartjan Tf AT
Bigdeli Tim B TB
Binder Elisabeth B EB
Bryois Julien J
Buttenschøn Henriette N HN
Bybjerg-Grauholm Jonas J
Cai Na N
Castelao Enrique E
Christensen Jane Hvarregaard JH
Clarke Toni-Kim TK
Coleman Jonathan Ri JR
Colodro-Conde Lucía L
Couvy-Duchesne Baptiste B
Craddock Nick N
Crawford Gregory E GE
Davies Gail G
Deary Ian J IJ
Degenhardt Franziska F
Derks Eske M EM
Direk Nese N
Dolan Conor V CV
Dunn Erin C EC
Eley Thalia C TC
Escott-Price Valentina V
Hassan Kiadeh Farnush Farhadi FF
Finucane Hilary K HK
Foo Jerome C JC
Forstner Andreas J AJ
Frank Josef J
Gaspar Héléna A HA
Gill Michael M
Goes Fernando S FS
Gordon Scott D SD
Grove Jakob J
Hall Lynsey S LS
Hansen Christine Søholm CS
Hansen Thomas F TF
Herms Stefan S
Hickie Ian B IB
Hoffmann Per P
Homuth Georg G
Horn Carsten C
Hottenga Jouke-Jan JJ
Hougaard David M DM
Howard David M DM
Ising Marcus M
Jansen Rick R
Jones Ian I
Jones Lisa A LA
Jorgenson Eric E
Knowles James A JA
Kohane Isaac S IS
Kraft Julia J
Kretzschmar Warren W WW
Kutalik Zoltán Z
Li Yihan Y
Lind Penelope A PA
MacIntyre Donald J DJ
MacKinnon Dean F DF
Maier Robert M RM
Maier Wolfgang W
Marchini Jonathan J
Mbarek Hamdi H
McGrath Patrick P
McGuffin Peter P
Medland Sarah E SE
Mehta Divya D
Middeldorp Christel M CM
Mihailov Evelin E
Milaneschi Yuri Y
Milani Lili L
Mondimore Francis M FM
Montgomery Grant W GW
Mostafavi Sara S
Mullins Niamh N
Nauck Matthias M
Ng Bernard B
Nivard Michel G MG
Nyholt Dale R DR
O'Reilly Paul F PF
Oskarsson Hogni H
Owen Michael J MJ
Painter Jodie N JN
Pedersen Carsten Bøcker CB
Pedersen Marianne Giørtz MG
Peterson Roseann E RE
Peyrot Wouter J WJ
Pistis Giorgio G
Posthuma Danielle D
Quiroz Jorge A JA
Qvist Per P
Rice John P JP
Riley Brien P BP
Rivera Margarita M
Mirza Saira Saeed SS
Schoevers Robert R
Schulte Eva C EC
Shen Ling L
Shi Jianxin J
Shyn Stanley I SI
Sigurdsson Engilbert E
Sinnamon Grant Cb GC
Smit Johannes H JH
Smith Daniel J DJ
Stefansson Hreinn H
Steinberg Stacy S
Streit Fabian F
Strohmaier Jana J
Tansey Katherine E KE
Teismann Henning H
Teumer Alexander A
Thompson Wesley W
Thomson Pippa A PA
Thorgeirsson Thorgeir E TE
Traylor Matthew M
Treutlein Jens J
Trubetskoy Vassily V
Uitterlinden André G AG
Umbricht Daniel D
Van der Auwera Sandra S
van Hemert Albert M AM
Viktorin Alexander A
Visscher Peter M PM
Wang Yunpeng Y
Webb Bradley T BT
Weinsheimer Shantel Marie SM
Wellmann Jürgen J
Willemsen Gonneke G
Witt Stephanie H SH
Wu Yang Y
Xi Hualin S HS
Yang Jian J
Zhang Futao F
Arolt Volker V
Baune Bernhard T BT
Berger Klaus K
Boomsma Dorret I DI
Cichon Sven S
Dannlowski Udo U
de Geus E J C EJC
DePaulo J Raymond JR
Domenici Enrico E
Domschke Katharina K
Esko Tõnu T
Grabe Hans J HJ
Hamilton Steven P SP
Hayward Caroline C
Heath Andrew C AC
Kendler Kenneth S KS
Kloiber Stefan S
Lewis Glyn G
Li Qingqin S QS
Lucae Susanne S
Madden Pamela Af PA
Magnusson Patrik K PK
Martin Nicholas G NG
McIntosh Andrew M AM
Metspalu Andres A
Mors Ole O
Mortensen Preben Bo PB
Müller-Myhsok Bertram B
Nordentoft Merete M
Nöthen Markus M MM
O'Donovan Michael C MC
Paciga Sara A SA
Pedersen Nancy L NL
Penninx Brenda Wjh BW
Perlis Roy H RH
Porteous David J DJ
Potash James B JB
Preisig Martin M
Rietschel Marcella M
Schaefer Catherine C
Schulze Thomas G TG
Smoller Jordan W JW
Stefansson Kari K
Tiemeier Henning H
Uher Rudolf R
Völzke Henry H
Weissman Myrna M MM
Werge Thomas T
Lewis Cathryn M CM
Levinson Douglas F DF
Breen Gerome G
Børglum Anders D AD
Sullivan Patrick F PF
JOURNAL
VOLUME: 2
ISSUE: 2
TITLE: Biological psychiatry global open science
ISOABBREVIATION: Biol Psychiatry Glob Open Sci
YEAR: 2022
MONTH: Apr
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 2667-1743
ISSNTYPE: Electronic
MEDLINE JOURNAL
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
COMMENTS AND CORRECTIONS
GRANTS
GENERAL NOTE
KEYWORDS
KEYWORD
Antidepressant response
Depression
GWAS
Genetics
MDD
Polygenic score
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's